Yes—one group of diabetes medicines raised Hemoglobin by an average of 0.51 g/dL compared with a dummy pill. The medicines are SGLT2 Inhibitors, a type of drug used for type 2 diabetes. A review combined 10 studies of adults with this condition. Follow-up ranged from eight weeks to two years. The review excluded people with heart failure or end-stage kidney disease. It also excluded people with a blood disorder that causes excess red blood cells. Three trials, involving 171 people, compared these drugs with dummy pills. Alongside higher Hemoglobin, they found a rise in Hematocrit of 2.29 percentage points. That second measure shows how much of your blood consists of red blood cells. Records from routine care covered 9,646 people. The share with unusually high red blood cell levels rose from 2.4% to 9.7%. Severe cases occurred in 1.4%. Changes appeared early after treatment began. They also seemed to reverse after the medicine was stopped. The rise is clearer than what it means for health. Evidence about blood clots was limited. One study found clots in 10% of 100 people with excess red blood cells. That selected group does not show the risk for everyone taking these medicines. It also does not prove the medicines caused those clots. For BioSocial members, medication dates can add useful context to bloodwork trends. Comparing results before and after a medicine change may reveal patterns. Sharing the size and timing of changes can make community comparisons more useful. A higher result alone does not establish benefit or harm. What changes have you seen in your Hemoglobin numbers after starting a diabetes medicine?